BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 14730700)

  • 1. Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice.
    Hirahara Y; Bansal R; Honke K; Ikenaka K; Wada Y
    Glia; 2004 Feb; 45(3):269-77. PubMed ID: 14730700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of oligodendrocyte differentiation by galactosphingolipids.
    Bansal R; Winkler S; Bheddah S
    J Neurosci; 1999 Sep; 19(18):7913-24. PubMed ID: 10479693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactocerebroside and sulfatide independently mediate Ca2+ responses in oligodendrocytes.
    Dyer CA; Benjamins JA
    J Neurosci Res; 1991 Dec; 30(4):699-711. PubMed ID: 1787543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction pathways involved in interaction of galactosylceramide/sulfatide-containing liposomes with cultured oligodendrocytes and requirement for myelin basic protein and glycosphingolipids.
    Boggs JM; Gao W; Hirahara Y
    J Neurosci Res; 2008 May; 86(7):1448-58. PubMed ID: 18189317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactolipids in the formation and function of the myelin sheath.
    Dupree JL; Suzuki K; Popko B
    Microsc Res Tech; 1998 Jun; 41(5):431-40. PubMed ID: 9672425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial cell mitogens bFGF and PDGF differentially regulate development of O4+GalC- oligodendrocyte progenitors.
    Gard AL; Pfeiffer SE
    Dev Biol; 1993 Oct; 159(2):618-30. PubMed ID: 8405684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocyte maturation is inhibited by bone morphogenetic protein.
    See J; Zhang X; Eraydin N; Mun SB; Mamontov P; Golden JA; Grinspan JB
    Mol Cell Neurosci; 2004 Aug; 26(4):481-92. PubMed ID: 15276151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient reversion of O4+ GalC- oligodendrocyte progenitor development in response to the phorbol ester TPA.
    Avossa D; Pfeiffer SE
    J Neurosci Res; 1993 Jan; 34(1):113-28. PubMed ID: 8423632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of galactosylceramide and sulfatide in glycosynapses between oligodendrocyte or myelin membranes.
    Boggs JM; Gao W; Zhao J; Park HJ; Liu Y; Basu A
    FEBS Lett; 2010 May; 584(9):1771-8. PubMed ID: 19941861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development.
    Bansal R; Warrington AE; Gard AL; Ranscht B; Pfeiffer SE
    J Neurosci Res; 1989 Dec; 24(4):548-57. PubMed ID: 2600978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside.
    Bansal R; Stefansson K; Pfeiffer SE
    J Neurochem; 1992 Jun; 58(6):2221-9. PubMed ID: 1573402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfatide is essential for the maintenance of CNS myelin and axon structure.
    Marcus J; Honigbaum S; Shroff S; Honke K; Rosenbluth J; Dupree JL
    Glia; 2006 Mar; 53(4):372-81. PubMed ID: 16288467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation and differentiation of O4+ oligodendrocytes in postnatal rat cerebellum: analysis in unfixed tissue slices using anti-glycolipid antibodies.
    Warrington AE; Pfeiffer SE
    J Neurosci Res; 1992 Oct; 33(2):338-53. PubMed ID: 1453495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
    Massa PT; Wu C; Fecenko-Tacka K
    J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfatide species with various fatty acid chains in oligodendrocytes at different developmental stages determined by imaging mass spectrometry.
    Hirahara Y; Wakabayashi T; Mori T; Koike T; Yao I; Tsuda M; Honke K; Gotoh H; Ono K; Yamada H
    J Neurochem; 2017 Feb; 140(3):435-450. PubMed ID: 27861899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium receptor expression and function in oligodendrocyte commitment and lineage progression: potential impact on reduced myelin basic protein in CaR-null mice.
    Chattopadhyay N; Espinosa-Jeffrey A; Tfelt-Hansen J; Yano S; Bandyopadhyay S; Brown EM; de Vellis J
    J Neurosci Res; 2008 Aug; 86(10):2159-67. PubMed ID: 18438915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inductions of small heat shock protein 27 and 1-Cys peroxiredoxin in reactive astrocytes in sulfatide-deficient mouse spinal cord.
    Suzuki A; Yamaguchi Y; Hoshi T; Hayashi A; Baba H
    J Neurosci Res; 2007 Jul; 85(9):1921-32. PubMed ID: 17510974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neurons and astrocytes of adult rat brain.
    Pernber Z; Molander-Melin M; Berthold CH; Hansson E; Fredman P
    J Neurosci Res; 2002 Jul; 69(1):86-93. PubMed ID: 12111819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation.
    Deloulme JC; Raponi E; Gentil BJ; Bertacchi N; Marks A; Labourdette G; Baudier J
    Mol Cell Neurosci; 2004 Dec; 27(4):453-65. PubMed ID: 15555923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.